Structure-activity relationships of competitive NMDA receptor antagonists

被引:5
|
作者
Cheung, NS
OCallaghan, D
Ryan, MC
Dutton, R
Wong, MG
Beart, PM
机构
[1] MONASH UNIV,DEPT PHARMACOL,CLAYTON,VIC 3168,AUSTRALIA
[2] UNIV MELBOURNE,AUSTIN HOSP,DEPT MED,HEIDELBERG,VIC 3084,AUSTRALIA
[3] SWINBURNE UNIV TECHNOL,DEPT APPL CHEM,HAWTHORN,VIC 3122,AUSTRALIA
关键词
NMDA receptor; competitive antagonist; radioligand binding; neuroprotection; molecular modelling;
D O I
10.1016/0014-2999(96)00608-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The interaction of structurally constrained competitive NMDA receptor antagonists, (+/-)-cis-4-phosphonomethyl-2-piperidine carboxylic acid (CGS 19755), (2-amino-4,5-(1,2-cyclohexyl))-7-phosphonoheptanoic acid (NPC 12626), (+/-)-6-phosphonomethyl-decahydroisoquinoline-3-carboxylic acid (LY 274614), (S)-alpha-amino-5-phosphonomethyl[1,1'-biphenyl]-3-propanoic acid (SDZ EAB-515) and (S)-alpha-amino-5-phosphonomethyl[1,1':4',1 ''-terphenyl]-3-propanoic acid (SDZ 215-439), with their receptor was assessed using radioligand binding, protection against neurotoxicity in cortical neuronal cultures and computerised molecular modelling. All compounds inhibited the specific binding of [H-3]CGS 19755 and/or [H-3]CGP 39653 (inhibition constants 40-2000 nM), and protected neuronal cultures from NMDA-mediated injury (IC50 values 1.3-5.6 mu M). Quantitative conformational analyses indicated that the molecules fitted well to a NMDA receptor model. Our results draw attention to a deep hydrophobic pocket, defined by the bi- and terphenyl containing antagonists (SDZ EAB-515, SDZ 215-439), which may influence potency and selectivity.
引用
收藏
页码:159 / 162
页数:4
相关论文
共 50 条
  • [41] Synthesis and structure-activity relationships of novel P2Y2 receptor antagonists
    Funke, Mario
    Ko, Geun-Yung
    Weyler, Stefanie
    Hillmann, Petra
    Hoeltje, Hans-Dieter
    Mueller, Christa E.
    PURINERGIC SIGNALLING, 2010, 6 (01) : 84 - 84
  • [42] Structure-activity relationships of a novel series of melanin-concentrating hormone (MCH) receptor antagonists
    Arienzo, R
    Clark, DE
    Cramp, S
    Daly, S
    Dyke, HJ
    Lockey, P
    Norman, D
    Roach, AG
    Stuttle, K
    Tomlinson, M
    Wong, M
    Wren, SP
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (15) : 4099 - 4102
  • [43] Synthesis and structure-activity relationships of 9-substituted acridines as endothelin-A receptor antagonists
    Cheng, XM
    Lee, C
    Klutchko, S
    Winters, T
    Reynolds, EE
    Welch, KM
    Flynn, MA
    Doherty, AM
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (24) : 2999 - 3002
  • [44] Structure-activity relationships of lysophosphatidic acid: Synthesis and analysis of Edg receptor agonists and antagonists.
    Santos, WL
    Heise, CE
    Lynch, KR
    Macdonald, TL
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U687 - U687
  • [45] Synthesis and structure-activity relationships in a series of ethenesulfonamide derivatives, a novel class of endothelin receptor antagonists
    Harada, H
    Kazami, J
    Watanuki, S
    Tsuzuki, R
    Sudoh, K
    Fujimori, A
    Tokunaga, T
    Tanaka, A
    Tsukamoto, S
    Yanagisawa, I
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2001, 49 (12) : 1593 - 1603
  • [46] Structure-activity relationships of bioisosteric replacement of the carboxylic acid in novel androgen receptor pure antagonists
    Yoshino, Hitoshi
    Sato, Haruhiko
    Tachibana, Kazutaka
    Shiraishi, Takuya
    Nakamura, Mitsuaki
    Ohta, Masateru
    Ishikura, Nobuyuki
    Nagamuta, Masahiro
    Onuma, Etsuro
    Nakagawa, Toshito
    Arai, Shinichi
    Ahn, Koo-Hyeon
    Jung, Kyung-Yun
    Kawata, Hiromitsu
    BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (09) : 3159 - 3168
  • [47] Structure-activity relationships of neuropeptide YY1 receptor antagonists related to BIBP 3226
    Aiglstorfer, I
    Hendrich, I
    Moser, C
    Bernhardt, G
    Dove, S
    Buschauer, A
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (14) : 1597 - 1600
  • [48] Trisubstituted benzene leukotriene B-4 receptor antagonists: Synthesis and structure-activity relationships
    Konno, M
    Nakae, T
    Sakuyama, S
    Odagaki, Y
    Nakai, H
    Hamanaka, N
    BIOORGANIC & MEDICINAL CHEMISTRY, 1997, 5 (08) : 1649 - 1674
  • [49] Structure-activity relationships of oxime neurokinin antagonists: Oxime modifications
    Reichard, GA
    Spitler, J
    Aslanian, R
    Mutahi, MW
    Shih, NY
    Lin, L
    Ting, PC
    Anthes, JC
    Piwinski, JJ
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (05) : 833 - 836
  • [50] Structure-activity relationships of benzothiazole GPR35 antagonists
    Abdalhameed, Manahil M.
    Zhao, Pingwei
    Hurst, Dow P.
    Reggio, Patricia H.
    Abood, Mary E.
    Croatt, Mitchell P.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (03) : 612 - 615